Natalie Sun

Natalie Sun

Auto-generated profile, based on publicly available information

Natalie Sun

Department of Internal Medicine, Boston Medical Center, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SSSofia Shaikh
Sofia Shaikh
NSNatalie Sun
Natalie Sun
ACAndrew Canakis
Andrew Canakis
WPWilliam Y. Park
William Y. Park
Horst Christian WeberHorst Christian Weber
Horst Christian Weber
Irritable Bowel Syndrome (IBS) is a functional disorder of the gastrointestinal tract characterized by abdominal pain and altered bowel habits. It has a prevalence of 10 to 25% in the United States and has a high disease burden, as evidenced by reduced quality of life, decreased work productivity and increased healthcare utilization and costs. IBS has been associated with several intra-intestinal and extra-intestinal conditions, including psychiatric comorbidities. Although the pathophysiology of IBS has not been fully elucidated, it involves dysregulation of communication between the brain and gut (brain–gut axis) which is associated with alterations in intestinal motility, gut permeability, visceral hypersensitivity and gut microbiota composition. The purpose of this article is to review the role the gut microbiota plays in the pathophysiology of IBS, understand factors that affect the gut microbiome and explore the microbiome as a target of treatment.

1 March 2020 in Cell Metabolism
Verified
Journal Article
Closed access
TKTibor I. Krisko
Tibor I. Krisko
HNHayley T. Nicholls
Hayley T. Nicholls
CBCurtis J. Bare
Curtis J. Bare
CHCorey D. Holman
Corey D. Holman
GPGregory G. Putzel
Gregory G. Putzel
DCDavid E. Cohen
David E. Cohen

12 June 2024 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NSNatalie Sun
Natalie Sun
BPBrenton Prescott
Brenton Prescott
JMJiantao Ma
Jiantao Ma
AMArpan Mohanty
Arpan Mohanty
MLMichelle T. Long
Michelle T. Long
MWMaura E. Walker
Maura E. Walker

12 February 2024 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
SSSofia Shaikh
Sofia Shaikh
IJIsa Jacoba
Isa Jacoba
NSNatalie Sun
Natalie Sun
ECEnoch Chung
Enoch Chung
HKHaesook Kim
Haesook Kim
Horst Christian WeberHorst Christian Weber
Horst Christian Weber
INTRODUCTION: Significant knowledge gaps exist regarding clinicopathological profiling as well as treatment, surveillance, and survival of duodenal neuroendocrine tumors (dNETs). METHODS: We clinicopathologically characterized and identified racial differences among patients with dNETs at a large safety net hospital. Tumor grades were updated based on the World Health Organization 2019 NET classification, and overall survival was determined. RESULTS: We identified 17 dNETs and found no differences in clinicopathologic characteristics across racial groups. Pathological diagnosis was upgraded in 35% of dNETs, and age >65 years significantly shortened overall survival. DISCUSSION: Larger-scale studies are needed to determine the significance of these findings.